![]() |
|
|
a Departments of Nutritional Sciences and b Paediatrics, University of Toronto, c The Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada, M5G 1X8 and d Department of Agricultural, Food and Nutritional Sciences, University of Alberta, Edmonton, Canada, T6G 2P5
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: phenylalanine dietary protein humans amino acids stable isotopes
| INTRODUCTION |
|---|
|
|
|---|
Briefly, our original protocol involves a 2-d adaptation period to a
low 13C formula diet at a protein intake of 1 g ·
kg-1 · d-1, followed by measurement of
amino acid kinetics over an 8-h period using a stable-isotope tracer
infusion in the fed state (Zello et al. 1990a
), sampling
either plasma (Zello et al. 1990c
) or urinary (De Benoist et al. 1984
, Wykes et al. 1990
,
Zello et al. 1994
) free amino acid enrichments. In
comparison to previous methods employed to measure amino acid kinetics
and establish requirements using stable isotopes, this experimental
protocol is relatively noninvasive and the study period is short-term
(Zello et al. 1995
). Our latest paper describes the
measurement of lysine and phenylalanine kinetics following oral
infusion of the isotope (Bross et al. 1998
). By using
this protocol, we have the potential to study groups that have not been
investigated, such as infants, children and nonhealthy subjects.
However, it would be advantageous to be able to complete the
measurements in a single day, without prior adaptation to the formula
diet. This is of particular importance in patient groups for whom a
period of dietary control may impede treatment and cause undue stress.
The formula diet consists of a mixture of free amino acids, an amino
nitrogen-free liquid formula and protein-free cookies, allowing precise
modification of the amino acid, protein and energy content of the diet
(Zello et al. 1990b
). The diet provides adequate energy
and protein with a constant 13C content, thus allowing a
stable breath and whole body 13C enrichment to be
established. An individual's 13C enrichment is determined
by their typical dietary intake of 13C, which varies
significantly (Schoeller et al. 1980
). A low and stable
background 13C enrichment is essential in order to
accurately determine increments in enrichment due to the administration
of 13C-labeled amino acids. In healthy adult subjects, a
stable breath 13C enrichment can be achieved after four,
hourly formula meals, indicating a stable background enrichment in the
free amino acid pool (Bross et al. 1998
). Thus,
apparently no prior adaptation to a low 13C intake is
necessary as long as the baseline enrichments in breath and plasma are
measured following a minimal period in the fed state on the formula
diet. For the 2 d prior to the study day, this has meant that it
is possible to use a more acceptable source of dietary protein for the
population being studied, rather than the amino acid-based formula
diet. This improved study protocol was successfully implemented to
establish a requirement for dietary tyrosine in children with
phenylketonuria (Bross 1997
). As part of the treatment
of this inborn error of metabolism, these children are maintained on a
controlled protein intake, similar to the intake of protein on the
study day. However, to study other vulnerable groups, whose diet is not
controlled, it is necessary to establish whether adaptation to a
constant protein intake is indeed necessary.
The aim of this study was to investigate the effects, if any, of
variations in the intake of protein on the 2 d prior to measuring
amino acid kinetics, thus helping to determine whether it is necessary
to control dietary protein intake prior to investigating amino acid
metabolism at an intake of 1 g protein ·
kg-1 · d-1 on the study day.
Hoerr et al. (1993)
and Motil et al. (1994)
showed that adaptation to a different protein intake is
complete within 48 h. Therefore, our objective was to investigate
L-[1-13C]phenylalanine kinetics, at an
adequate protein intake of 1 g · kg-1 ·
d-1, following 2 d of adaptation to different protein
intakes, over a range considered to be representative of usual intakes
in this adult population. We chose to investigate the metabolism of
L-[1-13C]phenylalanine because this is used
as the indicator amino acid for the majority of our oxidation studies.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
Six healthy adult volunteers participated in the study on an outpatient basis in the Clinical Investigation Unit at The Hospital for Sick Children (HSC),4Toronto, Canada. Subject characteristics are detailed in Table 1. None of the subjects had a history of recent weight loss, endocrine disorders or medication use. The design and aims of the study, as well as potential risks involved, were fully explained to each subject and written consent was obtained. All procedures during the study were approved by the University of Toronto Human Experimental Committee and the Human Subjects Review Committee of HSC. Subjects received financial compensation for their participation.
|
Each subject was randomly assigned to each of three dietary protein levels of 0.8, 1.4 and 2.0 g · kg-1 · d-1. Each study consisted of 2 d of the prescribed protein intake followed by a single study day for the measurement of phenylalanine kinetics, using L-[1-13C]phenylalanine, at a protein intake of 1g · kg-1 · d-1. Study periods were separated by at least 1 wk, with subjects completing all three studies within 2 mo.
Diet and energy intakes.
Dietary intakes at the three protein levels were prescribed by a
registered dietitian based on the usual food intake of the individual
subjects as assessed by a brief diet history. For each of the dietary
intakes, protein was provided from the same foods in order to maintain
constant proportions in the intake of dietary amino acids. Energy
intakes were based on the FAO/WHO/UNU predictive equations
(FAO/WHO/UNU 1985
), multiplied by an activity factor of
1.7. Subjects were provided with a detailed diet prescription, a set of
diet scales and a measuring cup. All diets were agreed upon by the
subjects prior to each dietary period, and subjects were encouraged to
space the dietary intake throughout the day as three main meals and
intermittent snacks. No other food or beverages, including diet
products containing artificial sweeteners, were consumed during the 2-d
adaptation period. Compliance with the diet was assessed post-hoc from
analysis of plasma urea (Kesteloot and Joossens 1993
)
and the urinary urea-to-creatinine ratio (Middendorf et al. 1986
) of spot samples taken on the morning of the study day
(Lee and Arroyave 1966
).
On the study day the diet was provided as a low 13C
experimental formula developed for amino acid kinetic studies
(Zello et al. 1990b
). Energy intakes were prescribed as
above. The protein intake of 1 g · kg-1 ·
d-1 was provided entirely as a crystalline amino acid
mixture based on the composition of intact egg protein, in keeping with
our usual study protocol to minimize variation in the dietary intake of
13C on the study day. The amount of
L-[1-13C]phenylalanine given during the study
day was subtracted from the dietary provision of phenylalanine. The
total intake of phenylalanine was 14 mg · kg-1 · d-1 with a tyrosine intake of 40 mg ·
kg-1 · d-1 to ensure adequacy, as
determined previously (Zello et al. 1990a
).
The total duration of each isotope study was 10 h. The experimental diets were prepared in the research kitchen of HSC and portioned into 10 hourly meals each providing one twelfth of the total daily intake of protein and energy. Subjects had free access to water, but no other food or beverage was taken throughout the length of the study day.
Tracer protocol.
The tracers used in this study included NaH13CO3 (99 atom percent) and L-[1-13C]phenylalanine (99 atom percent), purchased from Merck, Sharp and Dohme (Montreal, Quebec) and Mass Trace (Woburn, MA), respectively. Isotope solutions were prepared in deionized water and stored at -20°C. Before dispensing, the isotope solutions were sterilized through a 0.22 µm Millipore filter (Millipore Corporation, Bedford, MA). Oral priming doses of NaH13CO2 (0.176 mg/kg) and L-[1-13C]phenylalanine (0.664 mg/kg) were given with the fifth hourly meal. Simultaneously, an hourly oral dosing protocol of L-[1-13C]phenylalanine (1.2 mg · kg-1 · d-1) was commenced and continued throughout the remaining 6 h of the study.
Sample collection and analysis.
We showed that urine can be used as a means of determining plasma amino
acid enrichments (Wykes et al. 1990
, Zello et al. 1994
). We chose to sample the plasma pool directly, rather than
via the urine, since there was no restriction on intravenous access in
this healthy adult population. Baseline samples of breath
CO2 and plasma were collected at 30, 20 and 10 min before
the initiation of the isotope protocol. As predicted (Bross et al. 1998
), a background (baseline) isotopic steady state was
achieved in all subjects within 4 h of commencing feeding. Samples
were also collected at isotopic steady state, during the period 210 to
330 min following the commencement of the isotope protocol, at 20-min
intervals. Breath samples were collected for 7 min through a ventilated
mask and passed through a vacuum extraction system (Pump VB0025, Vortex
Blower; Spencer Turbine Company, Windsor, CT). Breath CO2
was collected by trapping in 1 mol/L NaOH solution. To ensure complete
trapping, respiratory gases were bubbled through 10 mL of 1 mol/L NaOH
in a modified reflux condenser at a rate of 500 mL/min. The resulting
Na2CO3 solution was then injected into a
vacutainer (Vacutainer Brand 6441; Becton Dickenson Inc., Mississauga,
Ontario, Canada) and stored at -20°C. Carbon dioxide production was
measured twice during the study day for 20 min, using an indirect
calorimeter (2900 Computerized Energy Measurement System; Sensormedics,
Yorba Linda, CA).
The enrichment of 13C in breath CO2 was
measured on a dual inlet isotope ratio mass spectrometer (Vacuum
Generator Micromass 602D, Cheshire, England) using techniques described
previously (Jones et al. 1985
). Breath
13CO2 Enrichments were expressed as atoms
percent excess over a reference standard of compressed CO2
gas.
At the beginning of the study day, a 21-gauge needle was inserted into
a superficial dorsal vein in the right hand. This remained in situ
throughout the length of the study day. The 2-mL samples of
arterialized venous blood were collected into heparinized syringes
(AspiratorTM; Marquest Medical Products, Englewood, CO) and
placed on ice. Arterialized venous blood was obtained by heating the
hand inside a thermostatic chamber maintained at 60°C (Zello et al. 1990c
). Plasma was extracted following centrifugation at
4°C at 1500 x g for 20 min and stored at -20°C
until analysis.
Plasma-free [13C]phenylalanine enrichment was measured by
gas chromatography[selected ion monitoring-negative chemical
ionization]mass spectrometry (Hewlett-Packard 5890 Series; GC,
Mississauga, Ontario; VG Trio-2 quadropole MS system, Cheshire,
England). Free amino acids in 200 µL of plasma were derivatized
according to he method described by Patterson et al. (1991)
to their heptafluorobutyryl n-propyl esters.
Selected-ion chromatograms were obtained by monitoring mass-to-charge
ratios of 383 and 384 for [13C]phenylalanine
corresponding to the unenriched (m) and enriched
(m + 1) peaks, respectively. The areas under the peaks
were integrated by a digital DECp 4502LP computer, using a
Lab-Base program (VG Biotech, Altringham, England).
Estimation of isotope kinetics.
Phenylalanine kinetics were calculated according to the stochastic
model of Matthews et al. (1980)
, previously employed by
Zello et al. (1990a)
. Isotopic steady state in the
metabolic pool was represented by plateau in
free-[13C]phenylalanine in plasma and
13CO2 in breath, plateau being defined by the
absence of a significant slope, assessed by linear regression analysis.
The mean breath 13CO2 enrichments of the three
baseline and the five plateau samples were used to determine atoms
percent excess above baseline at isotopic steady state. The mean ratios
of the enriched peak (m + 1) to the unenriched
(m) for both the baseline and plateau samples were used to
calculate molecules percent excess.
Phenylalanine flux (µmol · kg-1 ·
h-1) was measured during isotopic steady state from the
dilution of the L-[1-13C]phenylalanine
infused into the plasma metabolic pool. The rate of
13CO2 released by phenylalanine tracer
oxidation (F13CO2: µmol
13CO2 · kg-1 ·
h-1) was calculated according to Matthews et al. (1980)
from the expiration of 13CO2,
using a factor of 0.82 to account for the 13CO2
retained in the body because of bicarbonate fixation (Hoerr et al. 1989
). The rate of phenylalanine oxidation (µmol ·
kg-1 · h-1) was calculated from the
F13CO2 and the plasma free phenylalanine
enrichment (Matthews et al. 1980
).
Data analysis.
Repeated measures analysis of variance was performed on the results for
urinary urea to creatinine ratio and plasma urea to determine
compliance with the dietary regimen (Proc GLM, SAS 6.12 for Windows;
SAS Institute Inc., Cary, NC). Analysis of variance was also performed
to assess the effect of prior protein intake on phenylalanine flux,
tracer oxidation and phenylalanine oxidation (Proc GLM, SAS 6.12 for
windows, SAS Institute Inc.), with post-hoc testing by Duncan's
multiple-range test. Where an effect was identified, the data were
analyzed for both linear and quadratic responses (Proc Mixed, SAS 6.12
for Windows, SAS Institute Inc.). Differences were considered
significant at P
0.05.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Previous studies provided limited information about the effect of acute
changes in protein intake on amino acid kinetics. Motil et al. (1994)
showed that, in response to changes in protein intake
from 1.0 g · kg-1 · day-1 to
either 0.4 or 1.5 g · kg-1 ·
day-1, alterations in the peak 13C enrichment
of CO2 following a bolus dose of 13C-leucine
are complete after 2 d. Hoerr et al. (1993)
also
showed that 80% of the changes in both leucine and lysine flux, in
response to changes in protein intake, occur within 1 d. The study
detailed here shows that in healthy adult volunteers the intake of
protein on the preceding 2 d may have an effect on amino acid
kinetics measured on the study day. Prior protein intakes were
controlled at 0.8, 1.4 and 2.0 g · kg-1 ·
day-1. These intakes were chosen to ensure an intake at or
above requirement for all subjects and to encompass wide variation in
daily protein intakes. Phenylalanine kinetics were measured at a
protein intake of 1 g · kg-1 ·
d-1, according to our existing protocol. Adequate energy
intakes were maintained throughout the study period to avoid any effect
on protein metabolism. A significant quadratic response was identified
such that results for phenylalanine flux (P = 0.012)
and oxidation (P = 0.009) were higher following protein
intakes of both 0.8 and 2.0 g · kg-1 ·
day-1, compared to 1.4 g · kg-1 · d-1.
Both plasma urea and the urinary urea-to-creatinine ratio responded to
increments in protein intake, as shown in Table 2
, indicating
compliance with the dietary prescription for the 24 h before the
study (Kesteloot and Joossens 1993
, Middendorf et al. 1986
). These samples were taken on the morning of study d 3
until 4 h after commencement of the formula diet and are therefore
partially influenced by the intake of protein on the study day. In
another study, samples from normal individuals were taken 3.5 h
following consumption of a standard protein meal (0.4 g/kg) indicating
stability in both plasma urea levels at 5.4 ± 0.3 mmol/L and
urinary urea-to-creatinine ratio at 30.8 ± 2.1 µmol/µmol,
without any restriction on the intake of protein on the preceding
2 d (Cheema-Dhadi & Halperin, 1993
). This paper
also indicates that there is minimal diurnal variation in the urinary
urea-to-creatinine ratio in normal individuals consuming a regular diet
and carrying out normal daily activities.
The observation of a significant quadratic response may be interpreted
merely as a statistical finding, resulting from natural variation in
the estimation of amino acid kinetics. In this study there does not
appear to be higher within-subject variability in comparison to
previous studies (Lazaris-Brunner et al. 1998
,
Zello et al. 1993
), which might have been expected if
prior protein intake did indeed alter phenylalanine kinetics. Slightly
higher within-subject variation may also be expected due to the
less-stringent study conditions. Apart from the changes in prior
protein intake, this study differs from these previous studies in that
the isotopes were administered orally and the subjects were adapted to
a mixed diet, rather than an experimental formula, of the 2 d
prior to the study day. Also, the timing of the menstrual cycle and the
use of oral contraceptives in our female volunteers were not controlled
for, as was done by Lazaris-Brunner et al. (1998)
.
Zello et al. (1993)
found within-subject coefficient of
variation (CV) of 3 to 16% for flux rates in adult males at intakes
above their individual requirement for the test amino acid.
Lazaris-Brunner et al. (1998)
found within-subject CV of
1 to 9% in adult females at intakes above requirement for the test
amino acid. The within-subject CV in flux for the present study ranged
from 12 to 19% in males and 2 to 11% in females. These appear to be
comparable to our earlier data from amino acid oxidation protocol and,
hence, suggest that the quadratic response observation may simply be a
statistical finding.
Alternatively, a biochemical mechanism could be sought to explain this
response. Differences in phenylalanine kinetics, measured at a protein
intake of 1.0 g · kg-1 · d-1,
may indicate that there was a carryover effect of the adaptation to the
previous protein intake. The increase in phenylalanine flux shown with
a prior protein intake of 2.0 g · kg-1 ·
d-1 could be due to adaptation to the higher intake of
protein. According to Motil et al. (1994)
two-thirds of
the increase in flux in response to a higher protein intake can be
attributed to a greater rate of oxidation. In the study presented here,
following 2 d of consuming 2.0 g of protein ·
kg-1 · d-1, phenylalanine oxidation as
also increased in response to this higher prior intake of protein.
Therefore, there was a carryover effect on oxidation of the high intake
of protein prior to the study day.
The quadratic response shown for the effect of prior protein intake on
phenylalanine oxidation may be due directly to the response identified
in the flux results. No significant effect was seen for
F13CO2, the rate of excretion of the label in
breath CO2 and a marker of the oxidation of the labeled
amino acid. The rate of phenylalanine oxidation is calculated from the
estimates of phenylalanine flux and F13CO2.
Calculation of the rate of oxidation involves greater error than the
independent measurement of its components, flux and
F13CO2. Amino acid requirements from IAAO
studies may be estimated from F13CO2 results
alone, rather than from calculated oxidation results (Duncan et al. 1996
, Zello et al. 1993
). Therefore, it may
not be necessary to adapt subjects to a constant protein intake when
only measurements of label oxidation are required.
Following the lowest protein intake in the present study (0.8 g · kg-1 · d-1), higher rates of
phenylalanine flux and oxidation were observed at the study intake of
1 g protein · kg-1 · d-1
than following a prior protein intake of 1.4 g ·
kg-1 · d-1. This observation is not
consistent with the concept of adaptation to the prior intake of
protein. Hoerr et al. (1993)
fed a diet deficient in
protein (0.1 g · kg-1 · d-1)
for 1 wk and the following day measured leucine and lysine fluxes at a
higher protein intake (1.5 g · kg-1 ·
d-1). Both leucine and lysine fluxes were only 80% of
expected at this protein intake, indicating adaptation to the
previously low intake. However, the metabolic response to such a
variation in intake (0.1 vs. 1.5 g · kg-1 ·
d-1) may not be comparable to the variations in intakes of
protein in this study.
In conclusion, protein intake on the 2 d prior to the study day
appears to influence the rate of phenylalanine kinetics measured on the
study day. The mechanism by which prior protein intake affects amino
acid kinetics cannot be explained biochemically, and may be merely a
statistical finding. It is unlikely that the number of subjects
involved in this study is too small, as we have repeatedly shown that
amino acid requirements can be defined from the response in amino acid
oxidation following intravenous isotope infusion from just six
subjects. More recently, such a response was also observed using oral
administration of the isotopes (Bross 1997
). At present,
it is prudent that protein intake be controlled for 2 d prior to
studies of phenylalanine metabolism.
| FOOTNOTES |
|---|
1 Supported by Medical Research Council of Canada,
Grant MT 10321; Mead Johnson Canada, Protein-Free Powder. ![]()
2 The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked ''advertisement'' in accordance with 18 USC section 1734 solely to indicate this fact. ![]()
3 Abbreviations used: CV, coefficient of
variation; HSC, The Hospital for Sick Children; IAAO, indicator amino
acid oxidation. ![]()
Manuscript received May 19, 1998. Initial review completed July 7, 1998. Revision accepted November 2, 1998.
| REFERENCES |
|---|
|
|
|---|
1. Ball R. O., Bayley H. S.. Tryptophan requirement of the 2.5-kg piglet determined by the oxidation of an indicator amino acid. J. Nutr. 1984;114:1741-1746.
2. Bross, R. (1997) Tyrosine requirements and resting energy expenditure in patients with phenylketonuria. Doctoral Thesis, University of Toronto, Toronto, Canada..
3.
Bross R., Ball R. O., Pencharz P. B.. Development of a minimally invasive protocol for determination of phenylalanine and lysine kinetics, in humans, during the fed state. J. Nutr. 1998;128:1913-1919.
4. Cheema-Dhadi S., Halperin M. L.. Relative rates of appearance of nitrogen and sulphurImplications for post-prandial synthesis of proteins. Can. J. Physiol. Pharmacol. 1993;71:120-127.[Medline]
5. De Benoist B., Abdulrazzak Y., Brooke O. G., Halliday D., Millward D. J.. The measurement of whole body protein turnover in the preterm infant with intragastric infusion of L-[1-13C]leucine and sampling of the urinary leucine pool. Clin. Sci. 1984;66:155-164.[Medline]
6.
Duncan A. M., Ball R. O., Pencharz P. B.. Lysine requirement of adult males is not affected by decreasing dietary protein. Am. J. Clin. Nutr. 1996;64:718-725.
7. FAO/WHO/UNU Expert Consultation. Energy and Protein requirements. Geneva: World Health Organization, 1985 . [Technical Report Series No. 724].
8. Fuller M. F., Garlick P. J.. Human amino acid requirementsCan the controversy be resolved?. Annu. Rev. Nutr. 1994;14:217-241.[Medline]
9.
Hoerr R. A., Matthews D. E., Bier D. M., Young V. R.. Effects of protein restriction and acute refeeding on leucine and lysine kinetics in young men. Am. J. Physiol. 1993;264(Endocrinol. Metab. 27):):E567-E575.
10.
Hoerr R. A., Yu Y.-M., Wagner D., Burke J. F., Young V. R.. Recovery of 13C in breath from NaH13CO3 infused by gut and veinEffect of feeding. Am. J. Physiol. 1989;257(Endocrinol. Metab. 20):):E426-E438.
11.
Jones P.J.H., Pencharz P. B., Bell L., Clandinin M. T.. Model for determination of 13C substrate oxidation rates in humans in the fed state. Am. J. Clin. Nutr. 1985;41:1277-1282.
12. Kesteloot H. E., Joossens J. V.. Relationship between dietary protein intake and serum urea, uric acid and creatinine, and 24-hour urinary creatinine excretionThe BIRNH Study. J. Am. Coll. Nutr. 1993;12:42-46.[Abstract]
13. Lazaris-Brunner G., Rafii M., Pencharz P. B., Ball R. O.. Tryptophan requirement in young women as determined by indicator amino acid oxidation with L-[1-13C]phenylalanine. Am. J. Clin. Nutr. 1998;68:303-310.[Abstract]
14. Lee M., Arroyave G.. Variation in urinary excretion of urea and N-methyl nicotinamide during the day, comparison with fasting levels. Archivos Lateinamericanos de Nutrition 1996;16:125-132.
15.
Matthews D. E., Motil K. J., Rohrbaugh D. K., Burke J. F., Young V. R., Bier D. M.. Measurement of leucine metabolism in man from a primed, continuous infusion of L-[1013C]leucine. Am. J. Physiol. 1980;238(Endocrinol. Metab. 1):):E473-E479.
16. Middendorf D. F., Hebert L. A., Zager R. A., Hartman J., Bitzel D.. Simple method for monitoring 24-hour urinary urea nitrogen excretion. J. Lab. Clin. Med. 1986;108:577-580.[Medline]
17.
Motil K. J., Matthews D. E., Bier D. M., Burke J. F., Munro H., Young V. R.. Whole-body leucine and lysine metabolismResponse to dietary protein intake in young men. Am. J. Physiol. 1981;240 (Endocrinol. Metab. 3):E712-E721.
18. Motil K. J., Opekun A. R., Montandon C. M., Berthold H. K., Davis T. A., Klein P. D., Reeds P. J.. Leucine oxidation changes after dietary protein intake is altered in adult women but lysine flux is unchanged as is lysine incorporation into VLDL-apolipoprotein B-100. J. Nutr. 1994;124:41-51.
19. Patterson B. W., Hachey D. L., Cook G. L., Amann J. M., Klein P. D.. Incorporation of a stable isotopically labelled amino acid into multiple human apolipoproteins. J. Lipid. Res. 1991;32:1063-1072.[Abstract]
20.
Schoeller D. A., Klein P. D., Watkins J. B., Heim T., MacLean Jr W. C.. 13C abundances of nutrients and the effect of variations in 13C isotopic abundances of test meals formulated for 13CO2 breath tests. Am. J. Clin. Nutr. 1980;33:2375-2385.
21. Waterlow J. C.. The requirements of adult man for indispensable amino acids. Eur. J. Clin. Nutr. 1996;50(Suppl 1):S151-S179.
22. Wykes L. J., Ball R. O., Menendez C. E., Pencharz P. B.. Urine collection as an alternative to blood samplingA noninvasive means of determining isotopic enrichment to study amino acid flux in neonates. Eur. J. Clin. Nutr. 1990;44:605-608.[Medline]
23. Young V. R., Bier D. M., Pellett P. L.. A theoretical basis for increasing current estimates of the amino acid requirements in adult man, with experimental support. Am. J. Clin. Nutr. 1989;30:80-92.
24.
Zello G. A., Pencharz P. B., Ball R. O.. Phenylalanine flux, oxidation, and conversion to tyrosine in humans studied with L-[1-13C]phenylalanine. Am. J. Physiol. 1990;259 (Endocrinol. Metab. 22):E835-E843.
25. Zello G. A., Pencharz P. B., Ball R. O.. The design and validation of a diet for studies of amino acid metabolism in adult humans. Nutr. Res. 1990;10:1353-1365.
26. Zello G. A., Smith J. M., Pencharz P. B., Ball R. O.. Development of a heating device for sampling arterialized blood from a hand vein. Ann. Clin. Biochem. 1990;27:366-372.
27.
Zello G. A., Pencharz P. B., Ball R. O.. Dietary lysine requirement of young adult males determined by oxidation of L-[1-13C]phenylalanine. Am. J. Physiol. 1993;264 (Endocrinol. Metab. 27):E677-E685.
28. Zello G. A., Marai L., Tung A.S.F., Ball R. O., Pencharz P. B.. Plasma and urine enrichments following infusion of L-[1-13C]phenylalanine and L-[ring[2H5]phenylalanine in humansEvidence for an isotope effect in renal tubular reabsorption. Met 1994;43:487-491.
29. Zello G. A., Wykes L. J., Ball R. O., Pencharz P. B.. Recent advances on methods of assessing dietary amino acid requirements for adult humans. J. Nutr. 1995;125:2907-2915.
This article has been cited by other articles:
![]() |
B. Juillet, H. Fouillet, C. Bos, F. Mariotti, N. Gausseres, R. Benamouzig, D. Tome, and C. Gaudichon Increasing habitual protein intake results in reduced postprandial efficiency of peripheral, anabolic wheat protein nitrogen use in humans Am. J. Clinical Nutrition, March 1, 2008; 87(3): 666 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A Humayun, R. Elango, R. O Ball, and P. B Pencharz Reevaluation of the protein requirement in young men with the indicator amino acid oxidation technique Am. J. Clinical Nutrition, October 1, 2007; 86(4): 995 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V Kurpad, M. M Regan, T. D. Raj, V. N Rao, J. Gnanou, and V. R Young The daily phenylalanine requirement of healthy Indian adults Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1331 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W-C. Hsu, W. Kriengsinyos, L. J. Wykes, M. Rafii, L. A. Goonewardene, R. O. Ball, and P. B. Pencharz Leucine Is Not a Good Choice as an Indicator Amino Acid for Determining Amino Acid Requirements in Men J. Nutr., April 1, 2006; 136(4): 958 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W-C Hsu, L. A Goonewardene, M. Rafii, R. O Ball, and P. B Pencharz Aromatic amino acid requirements in healthy men measured by indicator amino acid oxidation Am. J. Clinical Nutrition, January 1, 2006; 83(1): 82 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Furst and P. Stehle What Are the Essential Elements Needed for the Determination of Amino Acid Requirements in Humans? J. Nutr., June 1, 2004; 134(6): 1558S - 1565S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Moehn, R. F.P. Bertolo, P. B. Pencharz, and R. O. Ball Indicator Amino Acid Oxidation Responds Rapidly to Changes in Lysine or Protein Intake in Growing and Adult Pigs J. Nutr., April 1, 2004; 134(4): 836 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Morens, C. Bos, M. E. Pueyo, R. Benamouzig, N. Gausseres, C. Luengo, D. Tome, and C. Gaudichon Increasing Habitual Protein Intake Accentuates Differences in Postprandial Dietary Nitrogen Utilization between Protein Sources in Humans J. Nutr., September 1, 2003; 133(9): 2733 - 2740. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Riazi, L. J. Wykes, R. O. Ball, and P. B. Pencharz The Total Branched-Chain Amino Acid Requirement in Young Healthy Adult Men Determined by Indicator Amino Acid Oxidation by Use of L-[1-13C]Phenylalanine J. Nutr., May 1, 2003; 133(5): 1383 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Reid, A. Badaloo, T. Forrester, W. C Heird, and F. Jahoor Response of splanchnic and whole-body leucine kinetics to treatment of children with edematous protein-energy malnutrition accompanied by infection Am. J. Clinical Nutrition, September 1, 2002; 76(3): 633 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Kriengsinyos, L. J. Wykes, R. O. Ball, and P. B. Pencharz Oral and Intravenous Tracer Protocols of the Indicator Amino Acid Oxidation Method Provide the Same Estimate of the Lysine Requirement in Healthy Men J. Nutr., August 1, 2002; 132(8): 2251 - 2257. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R Gibson, F. Jahoor, L. Ware, and A. A Jackson Endogenous glycine and tyrosine production is maintained in adults consuming a marginal-protein diet Am. J. Clinical Nutrition, March 1, 2002; 75(3): 511 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Di Buono, L. J Wykes, R. O Ball, and P. B Pencharz Dietary cysteine reduces the methionine requirement in men Am. J. Clinical Nutrition, December 1, 2001; 74(6): 761 - 766. [Abstract] [Full Text] |
||||
![]() |
P. B. Darling, J. Grunow, M. Rafii, S. Brookes, R. O. Ball, and P. B. Pencharz Threonine dehydrogenase is a minor degradative pathway of threonine catabolism in adult humans Am J Physiol Endocrinol Metab, May 1, 2000; 278(5): E877 - E884. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||